SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd (INDO) is trending as rapidly escalating geopolitical tensions, including Iranian strikes on Saudi oil infrastructure and attacks near the Strait of Hormuz, are fueling a significant surge in oil prices. The community is highly bullish, anticipating a massive short squeeze and comparing its potential for parabolic gains to its historic run during past energy crises.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp. (BATL) is soaring amidst intense discussions surrounding escalating geopolitical tensions impacting Middle Eastern oil supply and shipping, leading to a surge in crude prices. The low-float oil producer is a focal point for traders anticipating a significant short squeeze due to high short interest and heightened market volatility.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending as escalating geopolitical tensions in the Middle East, marked by military strikes and disruptions to major oil and natural gas facilities, raise global supply and inflation concerns. The community is sharply divided, with many bears anticipating a significant market downturn while bulls advocate a "buy the dip" strategy, citing historical market resilience to geopolitical events.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing a significant surge following strong earnings and optimistic guidance, driven by robust hyperscale demand for its 800G and 1.6T transceivers, amplified by analyst upgrades and short-covering activity. The community is sharply divided, with bulls citing its essential role in AI infrastructure and potential for multi-year growth, while skeptics express concerns over its valuation, historical unprofitability, execution risks, and a recent stock offering.

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

United States Oil Fund (USO) is surging amidst escalating Middle East tensions and reports of shipping disruptions near the Strait of Hormuz, with the community actively debating if these events will spark a sustained crude oil price rally or lead to a swift reversal.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN CRYPTO is experiencing a surge fueled by robust community engagement and anticipation for the upcoming 4/20 celebrations, with its proponents highlighting a strong, resilient 'culture' aiming to be the global cannabis cryptocurrency on Solana, driving education and advocating for plant-based decentralization.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending following a solid Q4 earnings beat and a new five-year LNG supply agreement with Trafigura, reinforcing its strong growth trajectory. The community is actively discussing the stock's significant undervaluation compared to its rapidly expanding LNG capacity, emphasizing its strategic advantage in the spot market amid escalating geopolitical tensions in the Strait of Hormuz, which could further drive up global LNG prices and potentially trigger a short squeeze.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is trending sharply lower after the FDA indicated its Phase I/II data for the Huntington's disease gene therapy, AMT-130, is currently insufficient for a BLA and recommended a Phase III trial. The community is expressing widespread frustration over the FDA's perceived 'moving goalposts' on accelerated approvals, with intense debate emerging on the asset's path forward and whether this signals a buying opportunity or further decline.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is capturing market attention as escalating US-Iran tensions and potential disruptions in the Strait of Hormuz drive strong safe-haven flows, leading community discussion around gold's role as a critical hard asset during geopolitical uncertainty.

The AES Corp. engages in the provision of power generation and utility services through its renewable and thermal generation facilities and distribution businesses. It operates through the following segments: U.S. and Utilities Strategic Business Unit (SBU), South America SBU, MCAC SBU, Eurasia SBU. The U.S. and Utilities SBU segment consists of facilities in the United States, Puerto Rico and El Salvador. The South America SBU segment covers Chile, Colombia, Argentina, and Brazil. The MCAC SBU segment refers to Mexico, Central America, and the Caribbean. The Eurasia SBU segment handles operations in Europe and Asia. The company was founded by Dennis W. Bakke and Roger W. Sant in 1981 and is headquartered in Arlington, VA.

AES Corp.

AES Corp is trending as reports indicate BlackRock's Global Infrastructure Partners is nearing a multi-billion-dollar acquisition, fueling widespread debate among shareholders who believe the potential offer undervalues the company's critical role in supplying power to the rapidly expanding AI data center sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Olema Pharmaceuticals CEO Touts Palazestrant Edge as Oral SERDs Shake Out at Conference

Olema Pharmaceuticals (NASDAQ:OLMA) President and CEO Sean Bohen said the company believes the emerging oral selective estrogen receptor degrader (SERD) class has proven its value over the past year...

Olema Pharmaceuticals CEO Teases Fall OPERA-01 Readout, Q2 KAT6 Data and CFO/COO Exit

Olema Pharmaceuticals (NASDAQ:OLMA) is focused on developing endocrine therapies aimed at improving outcomes for patients with estrogen receptor (ER)-positive, HER2-negative breast cancer, CEO Sean...

This Olema Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

Olema Pharmaceuticals (NASDAQ:OLMA) Now Covered by Analysts at Stifel Nicolaus

Stifel Nicolaus assumed coverage on Olema Pharmaceuticals in a research report on Wednesday. They set a "buy" rating and a $48.00 price target for the company...

Candriam S.C.A. Increases Stock Position in Olema Pharmaceuticals, Inc. $OLMA

Candriam S.C.A. raised its stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Free Report) by 46.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Consensus Rating of "Moderate Buy" by Analysts

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) has been given an average rating of "Moderate Buy" by the ten brokerages that are currently covering the company, MarketBeat reports. One...

Short Interest in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Decreases By 12.5%

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) was the recipient of a large decrease in short interest in January. As of January 15th, there was short interest totaling 9,100,561 shares...

Olema Pharmaceuticals (NASDAQ:OLMA) Trading 7.7% Higher - Here's What Happened

Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 7.7% - Here's Why...

Olema Pharmaceuticals (NASDAQ:OLMA) Director Sells 10,000 Shares

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) Director Cyrus Harmon sold 10,000 shares of Olema Pharmaceuticals stock in a transaction on Tuesday, January 20th. The stock was sold at an...

Olema Pharmaceuticals (NASDAQ:OLMA) Director Cyrus Harmon Sells 10,000 Shares

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) Director Cyrus Harmon sold 10,000 shares of the firm's stock in a transaction that occurred on Tuesday, January 20th. The shares were sold...

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Olema Pharmaceuticals Inc

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

Current Price	$24.20
Prev Close	$24.39
Open	$24.19
Dividend Yield	0.00%
50-Day Moving Average	$26.05
Beta	0.95
Avg. Volume	1.2M
PE Ratio	-13.36

52-Week High	$36.26
52-Week Low	$2.86
Market Capitalization	$1.9B
EPS (Annual)	-$2.20
Price to Book	5.40
Revenue Per Employee	$0.00

OLMA
Olema Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OLMA News

OLMAOlema Pharmaceuticals Inc